1Szabo G, Veres G, RadovitsS T, et al. Cardioprotective effects of hydrogen sulfide. Nitric Oxide, 2011, 25: 201-210.
2Qipshidze N, Metreveli N, Paras K, et al. Hydrogen sulfide mitigates cardiac remodeling during myocardial infarction via improvement of angiogenesis. Int J Biol Sci, 2012, 8: 430-441.
3Huang J, Wang DM, Zheng JB, et al. Hydrogen sulfide attenuates cardiac hypertrophy and fibrosis induced by abdominal aortic coarctation in rats. Mol Med Rep, 2012, 5: 923-928.
5Furne J, Springfield J, Koenig T, et al. Oxidation of hydrogen sulfide and methanethiol tothiosulfate by rat tissues: A specialized function of the colonicmucosa. Biochem Pharmacol, 2001, 62: 255-259.
7Streeter E, NG HH, Hart JL. Hydrogen sulfide as a vasculoprotective factor. Med Gas Res, 2013, 3: 9.
8Yang G, Wu L, Jiang B, et al. H2S as a physiologic vasorelaxant Hypertension in mice with deletion of cystathionine r-lyase. Sciance, 2008, 322: 587-590.
9Lu M, Liu YH, Goh HS, et al. Hydrogen sulfide inhibits plasma renin activity. Am Soc N ephrol, 2010, 21 : 993-1002.
10Hamid T, Guo SZ, Kingery JR, et al. Cardiomyocyte NF-kB p65 promotes adverse remodelling, apoptosis, and endoplasmie retieulum stress in heart failure. Cardiovase Res, 2010, 89: 129-138.
3Li L,Whiteman M,Guan YY,et al.Characterization of a novel,water-soluble hydrogen sulfide-releasing molecule(GYY4137):new insights into the biology of hydrogen sulfide[J].Circulation,2008,117(18):2351-2360.
4Tang C,Li X,Du J.Hydrogen sulfide as a new endogenous gaseous transmitter in the cardiovascular ayatem[J].Curr Vase Pharmacol,2006,4(1):17-22.
5Kamoun P.Endogenous production of hydrogen sulfide in mammals[J].Amino Acids,2004,26(3):243-254.
6Mathai JC,Missner A,Kugler P,et al.No facilitator required for membrane transport of hydrogen sulfide[J].Proc Natl Acad Sci USA,2009,106(39):16633-16638.
7Libby P, Ridker PM, Maseri A. Inflammation and atherosclercsis. Circulation, 2002, 105: 1135-1143.
8Kharbanda RK, Walton B, Allen M, et al. Prevention of inflammation-induced endothelial dysfunction: a novel vasculo-protective action of aspirin.Circulation, 2002, 105: 2600-2604.
9Nakajima T, Schuhe S, Warrington KJ, et al. T-cell-mediated lysis of endothelial cells in acute coronary syndromes. Circulation, 2002, 105: 570-575.
10Verma S, Li SH, Badiwala MV, et al. Endothelin antagonism and interleuldn-6 inhibition attenuate the proatherogenic effects of C-reactlve protein.Circulation. 2002, 105: 1890-1896.
